Michael qualified from the University of Glasgow in 2009 and then worked in first opinion practice in Buckinghamshire and Northern Ireland. He then returned to the University of Glasgow in 2012 to further his training and experience in oncology by completing four years of additional training. He completed an ECVIM residency in oncology in 2016 and became a Diplomate of the European College of Veterinary Internal Medicine and a European Specialist in Oncology in 2017. Michael worked at a private referral practice in Surrey prior to joining Fitzpatrick Referrals. Earlier this year, Michael was awarded a Masters degree in Veterinary Medicine. This additional qualification researched canine mast cell tumours.
Michael said: "I am absolutely delighted to have joined Fitzpatrick Referrals Oncology and Soft Tissue hospital. I have had a long-standing ambition to work as part of the fantastic team here since visiting the hospital during my specialist training in 2015. At this visit, I immediately felt at home in a group of people driven to deliver the very best compassionate care for dogs and cats.
"My ambition is to develop the very best ways to minimise the impact that cancer has on animals. I know that Fitzpatrick Referrals is the best environment for me to be able to achieve this. Throughout the hospital, there is an amazing positive attitude and a collective drive to improve the overall care we can give to pets with cancer. I am also excited by the opportunity to be able to help others to achieve their goals in improving cancer care for pets."
Elanco Companion Animal Health - maker of Comfortis, the flea treatment for dogs - is hosting an online evening webinar on Tuesday 10th January to highlight what pet owners want from their vets.
The free webinar follows research into the perceptions of clients and veterinary surgeons as to what attributes constitute a 'good vet'1. According to Elanco, the research revealed a distinct mismatch between what vets think and what pet owners think. The webinar will highlight these differences and the steps veterinary professionals can take to address them. Additionally, it will provide veterinary professionals with the opportunity to learn more about Comfortis and ask questions of Elanco's technical consultants.
Presented by Alan Robinson BVSc MRCVS DMS, a business development consultant for independent veterinary practices, the webinar will start at 8.00pm and will account for two hours CPD. Veterinary surgeons and nurses wishing to book a place should visit www.thewebinarvet.com/comfortis.
For further information, please telephone 01256 353131, email elancoCAH.uk@lilly.com or contact your local Elanco key account manager.
Vetoquinol UK Limited has launched Ceftiocyl: a ready-to-use formulation containing 50mg/ml ceftiofur for use in cattle and pigs.
In cattle, Ceftiocyl can be used for the treatment of respiratory disease, acute interdigital necrobacillosis and acute post-partum metritis. In pigs, Ceftiocyl is licensed for the treatment of respiratory disease. Ceftiocyl has the added benefit of traceability stickers which are attached to each vial making it easier and quicker to record and monitor on-farm usage.
Susan Mitchell, Large Animal Product Manager at Vetoquinol UK Ltd said, 'We are delighted to be expanding our large animal anti infective range offering. Marbocyl 10% has been used for acute mastitis in the dairy sector for many years, the addition of Ceftiocyl to our portfolio enables us to provide a cost-effective treatment for both metritis and lameness.'
1. Willshire, J.A. & Bell, N, J. (2009) An economic review of cattle lameness. Cattle Practice 17, 136-141.
Euthasol vet is presented as a clear blue liquid, licensed for intravenous, intracardial and intraperitoneal usage. A dose of 140 mg/kg (equivalent to 0.35 ml/kg) is considered sufficient for all licensed routes of administration.
Euthasol vet comes in vials of 100ml and has a 28 day broached shelf life.
Dechra Brand Manager Claire Morgan said: "Choosing the correct product for euthanasia is vital for veterinary professionals and Euthasol vet offers a highly effective solution.
"The intravenous route of administration should be the route of choice. Where intravenous administration is impossible, the product may be administered via the intracardiac route in all named species.
"Euthasol's versatility in terms of the range of species in which it is licensed for use, coupled with its 400 mg/ml concentration, is set to make it a popular choice in practice."
For more information, visit www.dechra.co.uk
Bovilis Rotavec Corona is used for the active immunisation of pregnant cows and heifers, 12-3 weeks pre-calving, to raise antibodies against rotavirus, coronavirus and E. coli F5 (K99). Calves gain protection by drinking the fortified colostrum from their vaccinated mothers.
The company says the new license indication will mean greater usage flexibility for UK cattle producers focusing on immunity-led prevention of infectious calf scours.
MSD ruminant veterinary adviser Dr Kat Baxter-Smith said: "On the old license, this vaccine needed to be used within eight hours of opening, so this will be a significant benefit-led change for suckler beef and dairy producers.
"For all-year-round calving dairy herds, for example – that may want to vaccinate successive pregnant dams on different days – it will make an opened bottle of vaccine last much longer. Those running batch calving herds with a long calving period should also benefit. We hope this will help reduce unnecessary wastage of the vaccine on farm and save farmers money.”
MSD says it will still be crucial to store the vaccine properly – upright and refrigerated (at 2-8°C) before and after broaching, and after first use. A broached vial will be able to be used once more during the next 28 days after the first vaccination event and then discarded. Vaccination equipment such as needles and syringes should be sterilized. Use of a multi-dose syringe to minimise vaccine contamination and excessive broaching is recommended.
The vaccine vials should still be shaken well before use. The injection should be made through an area of clean, dry skin with precautions taken against contamination.
Teddy had initially been examined at another specialist centre where life-long medical management was recommended due to the complexity of his vascular abnormality.
His primary care veterinary surgeon, Dr Rachel Lang, then referred the case to Gerard.
The first step was a contrast CT scan of Teddy's liver to highlight the vascular abnormalities and take accurate measurements.
Teddy then underwent a transjugular coil embolisation of his shunts using fluoroscopic guidance.
This involved placing a stent in his caudal vena cava that spanned both abnormal communications, and then deploying multiple platinum coils into the shunts to occlude the vascular flow while ensuring portal hypertension did not develop. The entire procedure was completed in less than 60 minutes and was performed via a 2cm skin incision over his jugular vein.
Teddy made an excellent recovery from the procedure and is currently free of clinical signs and receiving no medication at home.
Rachel said: "I was really struggling to find a referral centre willing to take on Teddy's case as it was so unusual and had spent weeks contacting every local referral centre I had referred to in the past. I contacted Fitzpatrick's about his case and within an hour Gerard McLauchlan had rung back and actually sounded keen to see Teddy which was a delight after weeks of frustration. The referral process was very easy from my side and I've been kept well informed throughout. I wouldn't hesitate to refer a case again and only wish we were closer!”
Gerard said: “Teddy is a wonderful patient with an amazing family. We were delighted to be able to offer a solution to his problem that had been previously thought not possible. Teddy should now be able to enjoy an excellent quality of life without the need for long term medications or diet. Interventional Radiology provided new and minimally invasive options for many conditions including vascular abnormalities, urinary tract problems and various cancers.”
You can view the CTs in the VetSurgeon Clinical Reference Library here.
Dr Russell, 64, who waived his right to attend the hearing, was convicted in 2023 of three offences: making indecent photographs of a child, possessing 2,280 prohibited images of a child and possessing 109 extreme pornographic images that included moving images that were grossly offensive.
After pleading guilty to making indecent photographs/pseudo-photographs of a child, possessing a prohibited image of a child, and possessing extreme pornographic image/images portraying sexual acts with an animal, Dr Russell was sentenced at Winchester Crown Court to a two-year community order, a 30-day Rehabilitation Activity Requirement, 150 hours of community service and a forfeiture and destruction order of Seagate Drive, Toshiba hard drive and Lenovo tablet.
In addition, he was required to register with the police for 5 years and made subject to a Sexual Harm Prevention Order for five years.
He was also required to pay prosecution costs of £425 and £60 victim surcharge.
Counsel for the College submitted to the Disciplinary Committee that the nature and circumstances of the offences rendered Dr Russell unfit to practise as a veterinary surgeon.
The Committee considered there to be several aggravating factors including, actual (albeit indirect) injury to an animal or child; the risk of harm to an animal or child; sexual misconduct; premeditated conduct; and, that the offences involved vulnerable children and animals.
Neil Slater, chairing the Committee and speaking on its behalf, said: “The Committee has reached the conclusion that Dr Russell’s behaviour is fundamentally incompatible with being a veterinary surgeon, namely grave offences of a sexual nature.
"Dr Russell’s behaviour was so serious that removal of professional status and the rights and privileges accorded to that status is considered to be the only means of protecting the wider public interest and of maintaining confidence in the profession.
“The Committee has not taken this decision lightly, and, lest it be misinterpreted, it has not taken it in order to satisfy any notional public demand for blame and punishment.
"It has taken the decision because, in its judgment, the reputation of the profession has to be at the forefront of its thinking and ultimately this is more important than the interests of Dr Russell.
"The decision is not simply based on the fact that these offences were of a sexual nature but because they were repeated over a significant period of time and at a time when Dr Russell must have known, on his own plea of guilty, that what he was doing was wrong.
"Further, the Committee can discern no evidence that Dr Russell has insight into the gravity of the offence he has committed.
"The Committee has therefore directed the Registrar to remove his name from the Register forthwith.”
Dr Russell has 28 days from being notified of his removal from the Register to lodge an appeal with Privy Council.
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
‘Is neutering dogs doing more harm than good?’ (BVA Congress Theatre, Thursday 16th November 2023 at 10.30am), will explore the latest research into the science of neutering and its impact on dog health and welfare, particularly on behaviour, and will also consider the role of non-surgical alternatives.
The session will be chaired by BVA President Dr Anna Judson, joined by:
The BVA says statistics from its Voice of the Veterinary Profession survey show that among clients who chose to neuter their dogs last year, only 6% picked non-surgical options.
Awareness of these options is low, with vets reporting that 9% of their clients had requested information about non-surgical options when considering neutering, such as sustained-release implants to suppress testosterone production in male dogs.
Among those who considered non-surgical options, clients cited the cost and need for repeat treatments as their main concerns (mentioned by 67% and 58% of vets, respectively), followed by individual variation in the effect and duration of non-surgical alternatives (22% of vets).
Anna said: “Canine neutering is a firmly established part of preventive pet healthcare in the UK, but it is also very much a live discussion within the veterinary profession, with a healthy ongoing debate around its merits and risks, based on evolving evidence.
"BVA’s survey shows low awareness among clients about all available neutering options for their pets, with only a tiny percentage choosing to go down the non-surgical route.
“Our BVA Congress discussion will offer vet professionals in small animal practice insight into the latest research on neutering, including potential longer-term impacts on a dog’s health and behaviour, and views on what that might mean for how vets discuss neutering options with clients.
"The panellists will also share useful tips on how to deal with clients’ questions about surgical and non-surgical options for their pets.”
https://bvajournals.onlinelibrary.wiley.com/toc/20427670/2023/193/S1
The clinic is led by Sebastien Behr MRCVS, an RCVS Specialist in Neurology. Patients will benefit from access to the referral centre's MRI scanner and its specialist imaging, anaesthesia and neurology teams.
Dr Behr said: "We are very excited to have launched this specialist clinic. Following detailed consultations with pet owners, the animals will be treated to the very highest level and bespoke care designed for each patient."
The practice is offering a fixed price package for routine diagnostic procedures.
For more information, visit www.willows.uk.net or contact the neurology team on 0121 721 7070.
The company says the system uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence to deliver accurate testing results at the time of visit, within 9 minutes in fact, giving veterinary surgeons the ability to diagnose and treat patients quickly, without the need for a second appointment.
Vetscan Imagyst will detect the eggs, cysts, and oocysts of whipworm, hookworm, roundworm, Giardia, and coccidia
Richard Goldstein, DVM, DACVIM, DECVIM-CA, VP Global Diagnostics Medical Affairs at Zoetis, said: "Parasites are a threat throughout the year, making routine monitoring critical to pet health.
“With Vetscan Imagyst, the ability to have accurate, fast results at the point-of-care empowers veterinarians to diagnose and treat in the same visit, increasing compliance and eliminating follow-up appointments and call backs, thus enhancing the overall pet owner experience.”
Vetscan Imagyst will launch in the UK next week. For more information, contact your Zoetis representative or visit at www.vetscanimagyst.com.
Dechra Veterinary Products has launched a 5 ml bottle of Comfortan (methadone), its titratable analgesia for cats and dogs.
The new sized bottle of Comfortan, designed for use with animals in, or about to experience, moderate to severe pain, is now available from veterinary wholesalers.
Dechra Brand Manager Craig Sankey said: “The new 5ml bottle is a great size for practices which would like to introduce Comfortan into their practice protocols, allowing them to do so in a cost-effective way.
“The availability of a smaller bottle will also be a benefit to practices which due to different surgical needs, currently only use Comfortan in a small number of cases. They will then be able to simply and easily trade up to the 10 ml bottle once they start to use Comfortan on more cases.”
The 5 ml has also been introduced in response to demand from branch practices which had been transferring 10ml bottles between sites and for cat-focused practices which use smaller volumes of the product.
The Care About Cushing’s website is designed to give horse owners the information they need to spot the signs of Cushing's, thereby prompting diagnosis by their veterinary surgeon.
The online resource includes monitoring tools, personalised alerts, owner guides and webinars. It also offers downloadable self-assessment checklists on Cushing’s disease and laminitis to take owners through the signs to look out for.
Owners whose horses have been diagnosed with Cushing’s are encouraged to sign up as a Care About Cushing’s member to keep up-to-date with the latest information about the disease and create a personal profile for their horse in order to monitor progress. One of the membership benefits is an 'ask the expert' section where members can ask questions about Cushing’s disease and laminitis.
The Care About Cushing’s resource supports Boehringer’s ‘Talk About Laminitis’ initiative to raise awareness of the signs of laminitis and its link with Cushing’s disease.
Talk About Laminitis now runs throughout the year and as part of the campaign the laboratory fees for the blood test which detects Cushing’s (the basal ACTH test) are free.
Liz Barrett, equine business head at Boehringer, said: "Our Talk About Laminitis disease awareness initiative has been hugely successful in highlighting the link between laminitis and Cushing’s disease and helping to diagnose Cushing’s. So much so that Cushing’s is now in the top five equine diseases recorded in the UK1."
For further information on Talk About Laminitis or Care About Cushing’s, visit www.talkaboutlaminitis.co.uk, www.careaboutcushings.co.uk or contact your local Boehringer territory manager.
Reference
Veterinary Review and Practice Heart magazines have ceased publication.
The former was first launched 15 years ago by John Alborough, and sold to Onstream Communications in May 2007.
Mark Johnston, Managing Director of Onstream Communications said: "It wasn't commercially viable running a full publishing team for two magazines, especially in the current economic environment, so we're consolidating our activities and concentrating on electronic media".
These include the peer-reviewed online clinical information services: Canis, Felis, Equis and Lapis and the provision of websites for veterinary practices and companies wishing to promote themselves and their products and services.
EnteroZoo is a dietary supplement composed of organic mineral and purified water in a gel suspension. Enteromed says it works by binding bacterial toxins as it passes through the animal's digestive tract, thereby helping to maintain a healthy gut and intestinal balance.
Enteromed says that compared to old classic adsorbents, such as clay or charcoal, EnteroZoo can be used long-term and is gentle on an animal's intestines.
The company points to a new in-vitro study from Brighton University School of Pharmacy & Biomolecular Sciences which has shown that EnteroZoo adsorbs E. coli, Shigella and C. difficile toxins1 – common causes of gastrointestinal infection and diarrhoea.
EnteroZoo is suitable for all animals including pregnant and nursing females. It is tasteless and odourless and the company says animals generally accept it without any problems. It can be administered in various ways: directly into the mouth, mixed into feed, put on a treat, mixed in an appropriate amount of water or administered with a plastic syringe into the oral cavity.
For more information, contact: enterozoo@enteromed.co.uk, or visit: www.enterozoo.co.uk
The programme offers a structured and heavily supported first year in practice, including hands-on surgical training and seminars from Advanced Veterinary Practitioners, at the Pets'n'Vets' Roundhouse Veterinary Hospital in Glasgow.
Totally Grad! also includes a mentor plan and additional monthly benchmarking and seminars and support.
Oliver Jackson, partner at Pets'n'Vets said: "We are well aware that many larger veterinary entities run new graduate programmes and we are proud to say that Totally Grad! offers great advantages that come with our independent structure.
"Independent practice can offer a rewarding working environment for new graduates – particularly progressive practices such as ours. We can offer new graduates not only the close-knit, friendly, helpful, stable, first-opinion experience, but also provide opportunities for career growth and development.
"We have the facility for graduates to explore their particular areas of interest. Indeed, in our practice it is possible for a new graduate to change our way of working – the decision-makers are available and listening. We now have many vets working with us who have come through the practice from our graduate system and who have gone on to help shape our practice.
"The success of our Laparoscopic and Cardiology clinics can be attributed to those vets, as can various other client service initiatives and ways of working. New blood brings new ideas and we welcome that."
Totally Grad! will also be open to fellow independent practices.
Oliver added: "By opening up our Totally Grad! programme, we are offering a simple, accessible facility to those fellow independent practices able and willing to provide a mentor and allow their graduate vets to be out of their practice for one or two days per month over a 12 month period. It fits perfectly with our Roundhouse Referrals offering which offers advice, CPD and support to local practices."
Any independent practices interested in participating in the programme can contact oliver.jackson@petsnvets.org while final year students interested in learning more about the programme can visit the website at www.totallygrad.co.uk and/or email Karen W at hello@totallygrad.co.uk
According to the BVA, the problem is usually related to the cost of treatment, with 90% of vets saying that they or a member of their team have been challenged over their fees or charges and 98% saying that at some time they feel under pressure to waive fees or accept the promise of late payment.
Predictably, the problem is more commonly reported by those working in companion animal or mixed practice, with 89% reporting some form of intimidating experience. Younger vets and female vets were also significantly more likely to have experienced some form of intimidation.
The survey has prompted the BVA and the British Veterinary Nursing Association to issue advice concerning how to deal with intimidating clients.
BVNA President Sam Morgan said: "These statistics make for sad reading, but are certainly not surprising. Working within practice we have all either been subject to or witnessed that 'difficult' client, but we must remember any form of harassment is unacceptable. It’s important not to feel alone in these situations and to ensure there is awareness and support throughout the veterinary team."
BVA President John Fishwick, said: "Every situation is different and has to be dealt with on an individual basis, but it’s concerning to see the figures around challenging client behaviour and fees. Owning an animal is an important responsibility and will cost tens of thousands of pounds over its lifetime.
"It’s important for everyone in the vet team to take pride in the healthcare and treatment they deliver, and, equally, they must feel valued for their services. These figures emphasise the importance of managing expectations around fees by ensuring a two-way discussion about options and costs so clients can make a decision in collaboration with the veterinary team."
The BVA/BVNA advice for dealing with intimidating clients is as follows:
Photo: Dimitry A / Shutterstock
The Wellington-based hospital is hoping to announce its first resident at the start of next year, who will work under the guidance of Fran Taylor-Brown and Tom Cardy.
This is the first residency programme to be conducted at Cave and has been launched by Fran who, along with Tom, is an EBVS and RCVS specialist in veterinary neurology.
Fran said: "The ECVN accreditation is an important milestone for us as we look to develop and expand our expertise in neurology.
"We are currently undertaking a major recruitment drive and having the capability to offer specialist training in this discipline is another feather in the cap.
"We’re hopeful this approval will open the door to allow clinicians in other disciplines to receive specialist-level training with us in the future."
Cave has also introduced an internship programme to support the growth of the team and has taken on Samantha Gilbert a graduate of James Cook University in Australia.
According to Davies, Sharpsmart is the world’s safest and most environmentally responsible sharps and clinical waste management system, proven to:
Ellie West, anaesthetist at Davies and Green Group leader said: "We are really excited to have the opportunity to be the first veterinary centre to be working with Sharpsmart and are already seeing great results in carbon reduction and we look forward to sharing our results later in 2019."
Adrian Giles, Total Waste Program Manager for Sharpsmart added: "Working with Davies has enabled us to showcase our safety engineered sharps system in a new and exciting arena where sharps safety and sustainability are a priority.
"The transition to Sharpsmart was seamless and was completed across the centre in a day without any challenges. Face-to-face training was provided to staff along with touch point education material. We look forward to strengthening our partnership with Davies over the coming months and years."
As part of its green drive, Davies will be hosting 'Sustainability CPD' for referring vets on May 2nd 2019 at its HQ in Higham Gobion, Hertforshire.
Ellie West said: "Run by the Sustainability Leads at DVS, this evening aims to increase your carbon literacy, explore the challenges and barriers to improving sustainability in your daily practice and find some positive solutions to implement sustainability. The challenges which we have faced at DVS will be explored, along with the co-benefits of sustainability to our business, and useful resources to help your practice to be more environmentally friendly and resilient will be highlighted."
You can book your place here https://vetspecialists.co.uk/events/davies-first-sustainability-cpd-for-referring-vets/ or contact Ellie.West@vetspecialists.co.uk if you are interested in attending or would like more information.
Davies has also produced a suite of Waste Segregation Posters which are proving popular with their referring practices. You can find out more and view the posters here https://vetspecialists.co.uk/sustainability/sustainability-initiatives-at-davies-your-questions-answered/.
For more information or to receive print ready PDFs, contact marketing@vetspecialists.co.uk
Hill's Pet Nutrition is to launch Prescription Diet y/d Feline for the nutritional management of feline hyperthyroidism in May.
According to the company, hyperthyroidism is the most commonly diagnosed endocrinopathy in cats globally, and is thought to affect around 10% of cats over the age of nine in the UK.1.
Prescription Diet y/d Feline is clinically proven to manage thyroid health in three weeks3 and gives vets a new management modality to address the needs of hyperthyroid cats. Hill's says that the new product is essentially a low iodine food; production of thyroid hormones T3 and T4 require iodine molecules, so limiting the amount of dietary iodine reduces the amount of thyroid hormones produced and released by the thyroid gland.
Hill's highlights three key studies in peer reviewed veterinary journals which the company says demonstrates the efficacy of y/d.2-4 The research identified that limiting the amount of iodine consumed resulted in a lowering of T4 (serum total thyroxine) to normal levels, with significant reductions in just 3 weeks.2
Hill's says that the availabillity of nutrition as a treatment option marks a major step forward from invasive surgery, treatment with radioactive iodine - which is available in only a few centres in the UK - or pilling, which can prove to be particularly difficult for some pet owners. The company adds that a gradual transition to y/d is also an option where medical treatment is proving problematic.
Cats with hyperthyroidism have a multisystemic disease and concurrent problems can develop, such as hypertension, cardiovascular abnormalities and recurrent urinary infections. Additionally, many older cats with hyperthyroidism have concurrent renal dysfunction, which is often 'unmasked' when the hypertension is bought under control. Therefore, y/d also has controlled levels of phosphorus and low sodium for renal and circulatory health, reduced magnesium and moderate urine pH target for urinary health and taurine and carnitine for heart health.
Hill's Prescription Diet y/d Feline will be available from 1st May.
For more information, visit www.catthyroidhealth.com
References
1. Symes H, Winter 2008/2009. Feline hyperthyroidism. The Endocrinologist. Issue 90, pp 10-12. Symes H, Winter 2008/2009. Feline hyperthyroidism. The Endocrinologist. Issue 90, pp 10-12.2. Controlled level of dietary iodine normalizes serum total thyroxine in cats with naturally occurring hyperthyroidism Yu S, Wedekind KJ, Burris PA, et al. J Vet Intern Med 2011;25:683-684 (abstract).3. Titration of dietary iodine for reducing serum thyroxine concentrations in newly diagnosed hyperthyroid cats Melendez LD, Yamka RM, Forrester SD, et al. J Vet Intern Med 2011;25:683 (abstract).4. Titration of dietary iodine for maintaining normal serum thyroxine concentrations in hyperthyroid cats Melendez LD, Yamka RM, Burris PA. J Vet Intern Med 2011;25:683 (abstract).
The company says that the composition and dosage of the new product has been optimised for maximum efficacy 1, 2. It offers three-five days on-label treatment options and does not need to be stored in a fridge.
According to Boehringer, the 600mg dose results in a concentration well above MICs for Strep. uberis and Staph. aureus for 24 hours, even after milking, which means it needs to be administered once a day1. In addition, its formulation enables optimum distribution of penicillin throughout the udder2.
Kath Aplin veterinary adviser at Boehringer Ingelheim said: "Traditionally, in the UK, we have favoured broad spectrum mastitis therapy as our first line approach, however in many other European countries, including The Netherlands, Belgium, Sweden and Denmark, penicillin is the treatment of choice.
"For farms with a mixed or unknown mastitis pattern, the traditional broad spectrum approach to mastitis therapy makes sense. However, many vets now have a good knowledge of common mastitis pathogens on clients’ farms and, for those where gram +ve pathogens predominate, penicillin as a first line treatment is well worth considering."
In a field trial assessing the prevalence of mastitis-causing pathogens and clinical cure rates after treatment with Ubropen3, mild and moderate cases of mastitis were treated for three to five days, with the causal pathogen being unknown at the time of treatment.
Kath said: “In 80% of cases of grade one or two clinical mastitis, the causative pathogen was found to be gram +ve and, following treatment with Ubropen, the overall clinical cure rate was 81%".
Ubropen is now available from the usual veterinary wholesalers in boxes of 20 tubes.
References:
Novartis Animal Health has issued the following statement concerning the supply of acepromazine (ACP) injectable in the UK:
"Recent upgrades to Novartis Animal Health’s manufacturing plant in the UK have resulted in the site becoming a worldwide centre of excellence for the production of bulk liquids. This upgrade has had an impact on the manufacture of ACP 2mg/ml and 10mg/ml injectable products, which will no longer be produced in the UK.
From January 2011, Novartis Animal Health will no longer be able to supply ACP Injection 2mg/ml or ACP Injection 10mg/ml to wholesalers. However, it is not Novartis’ intention to discontinue the supply of acepromazine injectable; in order to ensure consistency of supply to the UK market the company will be importing the Vetoquinol French product Calmivet.
Calmivet is a monovalent acepromazine injection licensed for use in dogs, cats and horses, available as a 5mg/ml injection, 50ml vial.
In order to obtain Calmivet from wholesalers, veterinarians will need to apply for a free of charge Special Import Certificate from the VMD. This can be completed on line at www.vmd.gov.uk.
It is anticipated that this situation will continue for at least the first 6 months of 2011, until an alternative manufacturing site is established. As soon as we have more information on the timelines this will be communicated.
A full communication including a prep room reminder poster and Calmivet product leaflet has been mailed to all UK practices.
Vetoquinol UK are not responsible for the distribution or technical support of this product, so any queries should be directed to Novartis Animal Health UK on 01276 694402.
The production and supply of ACP Tablets 10mg remains unaffected."
One of the consequences of veterinary price inflation has been a backlash from owners against vets, vet nurses and receptionists, so the first film kicks off by explaining why large vet bills are not the fault of the vet standing in front of them when their dog gets ill.
Currently, a further eight films are now in production, each looking at a different reason why the costs of veterinary care have increased and suggesting ways that owners can mitigate the impact. They are:
VetSurgeon.org Publishing Editor, Arlo Guthrie, who presents the films, said: "Above all, the aim here is to foster a better understanding between veterinary professionals and owners.
"I do hope the vets, nurses and support staff who have been bearing the brunt will feel my films are helpful.
"If you do feel they make useful points, then you need to share and 'like' the hell out of them on all the different social media platforms, in order that they reach the largest number of people.
"And if you have feedback about the content, or ideas for other topics we should cover, then come and post here: https://www.vetsurgeon.org/f/non-clinical-questions/31062/why-have-vet-bills-gone-up-so-much/245723"
The film is available here:
TIKTOK: https://www.tiktok.com/@vetsurgeon.vetnurse/video/7426457335880617248
YOUTUBE: https://www.youtube.com/shorts/lg_EeamSbSI
FACEBOOK: https://www.facebook.com/reel/927062139289036
LINKEDIN: https://www.linkedin.com/posts/vetsurgeon-org_veterinarysurgeon-veterinarynurse-activity-7252420794004205568-LzE3/
INSTAGRAM: https://www.instagram.com/reel/DBM5i2XtfOB/
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
The charity launched the 'Cat Friendly Clinic' accreditation scheme in 2012, in order to raise standards and reduce the stress experienced by cats (and consequently their owners) when visiting clinics.
In order to be accredited as a Cat Friendly Clinic, a clinic must not only meet high standards of cat care in terms of facilities and equipment, but staff must also demonstrate an understanding of the needs and behaviour of cats and put in place measures to ensure that visits to the clinic are more cat-friendly.
In the six years since its inception, the scheme has become a well-recognised standard in feline veterinary care, with accredited clinics all over the world.
The Classic Animal Hospital in South Korea (wow, see the architects' photos here), was founded in September 2017 and consists of three vets, eight nurses and three receptionists. Open 24 hours a day, 365 days a year, the clinic's goal is to "provide outstanding veterinary care using the most advanced medical techniques and equipment in an environment that is both comfortable and welcoming for owners and their loved companions’. Currently, about 30% of the clinic’s clients are cats, and this percentage is continuing to grow.
Park Sungwon, owner of the clinic and Chief of Surgery, said: "Since more and more Koreans are having cats as their companion animals, there is growing interest in the Cat Friendly Clinic programme. So many veterinarians who have just started or want to start their own clinic share information about becoming a Cat Friendly Clinic. I also found out about the Cat Friendly Clinic scheme on the vet internet community. When I decided to open my clinic, I planned to become a Cat Friendly Clinic. So I took ISFM’s requirements into consideration when I designed my clinic."
When asked what cat owners think of the clinic’s Cat Friendly status, Park said: "They are very satisfied with our separated, quiet, cat-only waiting area and large hospitalisation facilities. They think that their cats definitely feel more comfortable at my clinic than they feel at other clinics in my town."
Sarah Endersby, International Cat Care’s Veterinary Development Manager, said: "We are delighted to have accredited the 1000th Cat Friendly Clinic. It is fabulous to know that many veterinary clinics around the world are thinking about how they can make feline visits less stressful, benefitting not only the cats themselves, but their owners and the veterinary team. We have many clinics looking to become a Cat Friendly Clinic, so the community is growing quickly - hopefully we will be welcoming the 2000th clinic in the not too distant future!"
To find out more about the Cat Friendly Clinic scheme, visit catfriendlyclinic.org.
The scheme is supported by six official partners: Boehringer Ingelheim, Ceva, Elanco, Idexx, Merial and Royal Canin.